Potentiation of cell-mediated immune responses directed against P. falciparum sporozoite peptide vaccine by immunomodulators.
Russo
D M
DM
Department of Microbiology and Immunology, Hahnemann University, Philadelphia, PA.
Sundy
J S
JS
Maguire
H C
HC
Weidanz
W P
WP
D000276:Adjuvants, Immunologic; D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D003520:Cyclophosphamide / Q000494:pharmacology; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular / Q000187:drug effects*; D007378:Interleukins / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010963:Plasmodium falciparum / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000953:Antigens, Protozoan; D007378:Interleukins; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D014612:Vaccines; D014614:Vaccines, Synthetic; D003520:Cyclophosphamide